Document is current
Any future updates will be listed below
-
Authors
Li, Yanpeng
Tong, Dongmei
Liang, Peibin
Lönnblom, Erik
Viljanen, Johan
Xu, Bingze
Nandakumar, Kutty Selva
Holmdahl, Rikard http://orcid.org/0000-0002-4969-2576
-
Funding
Funding for this research was provided by:
Guangdong Province Introduction of Innovative R&D Team (201001Y04675344)
Southern Medical University (G619310007)
Knut and Alice Wallenberg Foundation (Dnr KAW 2019.0059)
Swedish Association against Rheumatism (R-858181)
Swedish Medical Research Council (Dnr2017-06104, Dnr 2017-05835, Dnr 2015-02662, Dnr 2016-00288, Dnr 2015-06247)
Swedish Foundation for Strategic Research (Dnr RB13-0156)
Southern Medical University (C1051017)
- License Information
-
More Information
Article History
Received: 14 February 2020
Accepted: 27 March 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: All animal experiments were conducted in accordance with the guidelines of the National Institutes of Health (NIH publication no. 8023) and approved by the ethics committee of Southern Medical University (L2020013).
: Not applicable
: RH is the inventor of a filed patent protecting the L10D9 and 15A11 antibodies. The other authors declare an absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
